HomeMREO • NASDAQ
Follow
Mereo BioPharma Group plc - ADR
Previous close
$3.11
Day range
$2.99 - $3.14
Year range
$0.69 - $4.36
Market cap
433.35M USD
Avg Volume
1.55M
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 3.56M | — |
Operating expense | 7.29M | -34.20% |
Net income | -5.52M | 42.43% |
Net profit margin | -154.74 | — |
Earnings per share | — | — |
EBITDA | -4.92M | 53.95% |
Effective tax rate | 7.60% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 42.11M | -44.89% |
Total assets | 80.64M | -25.36% |
Total liabilities | 22.89M | -40.46% |
Total equity | 57.74M | — |
Shares outstanding | 125.42M | — |
Price to book | 6.76 | — |
Return on assets | -15.36% | — |
Return on capital | -18.47% | — |
Cash Flow
Net change in cash
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -5.52M | 42.43% |
Cash from operations | -6.63M | 29.48% |
Cash from investing | 65.50K | -86.55% |
Cash from financing | -458.00K | -213.70% |
Net change in cash | -7.11M | 20.47% |
Free cash flow | -2.44M | 52.81% |
About
Founded
2015
Website
Employees
36